Sage Therapeutics (SAGE) PT Lowered to $37 at Mizuho Securities, "Continue to Have Questions on zuranolone"
Tweet Send to a Friend
Mizuho Securities analyst Vamil Divan lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $37.00 (from $41.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE